108 related articles for article (PubMed ID: 27823641)
1. Adverse neuropsychological effects associated with cumulative doses of corticosteroids to treat childhood acute lymphoblastic leukemia: A literature review.
Pépin AJ; Cloutier-Bergeron A; Malboeuf-Hurtubise C; Achille M; Krajinovic M; Laverdière C; Lippé S; Marcoux S; Sinnett D; Sultan S
Crit Rev Oncol Hematol; 2016 Nov; 107():138-148. PubMed ID: 27823641
[TBL] [Abstract][Full Text] [Related]
2. A Bayesian multivariate latent t-regression model for assessing the association between corticosteroid and cranial radiation exposures and cardiometabolic complications in survivors of childhood acute lymphoblastic leukemia: a PETALE study.
Caubet Fernandez M; Drouin S; Samoilenko M; Morel S; Krajinovic M; Laverdière C; Sinnett D; Levy E; Marcil V; Lefebvre G
BMC Med Res Methodol; 2019 May; 19(1):100. PubMed ID: 31088361
[TBL] [Abstract][Full Text] [Related]
3. Measuring neurobehavioral side effects of corticosteroids in pediatric acute lymphoblastic leukemia: A scoping review.
Bhasin S; Brown J; Dorste A; Samsel C; Vrooman LM; Muriel AC
Pediatr Blood Cancer; 2024 Apr; 71(4):e30881. PubMed ID: 38263506
[TBL] [Abstract][Full Text] [Related]
4. Bone Mineral Metabolism During Chemotherapy in Childhood Acute Lymphoblastic Leukemia: Unexpected Vitamin D Deficiency From Induction Corticosteroids in Acute Lymphoblastic Leukemia.
Gahr K; Sommers N; Bostrom B
J Pediatr Hematol Oncol; 2021 Aug; 43(6):240-241. PubMed ID: 33290292
[No Abstract] [Full Text] [Related]
5. Psychiatric adverse effects of pediatric corticosteroid use.
Drozdowicz LB; Bostwick JM
Mayo Clin Proc; 2014 Jun; 89(6):817-34. PubMed ID: 24943696
[TBL] [Abstract][Full Text] [Related]
6. [Late sequelae of central nervous system prophylaxis in children with acute lymphoblastic leukemia: high doses of intravenous methotrexate versus radiotherapy of the central nervous system--review of literature].
Zając-Spychała O; Wachowiak J
Med Wieku Rozwoj; 2012; 16(2):128-37. PubMed ID: 22971657
[TBL] [Abstract][Full Text] [Related]
7. The impact of dexamethasone and prednisone on sleep in children with acute lymphoblastic leukemia.
Daniel LC; Li Y; Kloss JD; Reilly AF; Barakat LP
Support Care Cancer; 2016 Sep; 24(9):3897-906. PubMed ID: 27108263
[TBL] [Abstract][Full Text] [Related]
8. Late CNS sequelae in long term survivors of childhood leukemia.
Poplack DG; Browers P
An Esp Pediatr; 1988 Oct; 29 Suppl 34():19-26. PubMed ID: 3214030
[No Abstract] [Full Text] [Related]
9. Neurocognitive Outcome in Very Long-Term Survivors of Childhood Acute Lymphoblastic Leukemia After Treatment with Chemotherapy Only.
Kanellopoulos A; Andersson S; Zeller B; Tamnes CK; Fjell AM; Walhovd KB; Westlye LT; Fosså SD; Ruud E
Pediatr Blood Cancer; 2016 Jan; 63(1):133-8. PubMed ID: 26312396
[TBL] [Abstract][Full Text] [Related]
10. Cytoreduction and prognosis in childhood acute lymphoblastic leukemia.
Aricò M; Masera G
J Clin Oncol; 1997 Mar; 15(3):1285. PubMed ID: 9060574
[No Abstract] [Full Text] [Related]
11. Risk factors and management of corticosteroid-induced hyperglycaemia in paediatric acute lymphoblastic leukaemia.
Gregoriou K; Craigie I; Gibson B; Mason A; Shaikh MG
Pediatr Blood Cancer; 2020 Feb; 67(2):e28085. PubMed ID: 31736211
[TBL] [Abstract][Full Text] [Related]
12. Leukoencephalopathy and long-term neurobehavioural, neurocognitive, and brain imaging outcomes in survivors of childhood acute lymphoblastic leukaemia treated with chemotherapy: a longitudinal analysis.
Cheung YT; Sabin ND; Reddick WE; Bhojwani D; Liu W; Brinkman TM; Glass JO; Hwang SN; Srivastava D; Pui CH; Robison LL; Hudson MM; Krull KR
Lancet Haematol; 2016 Oct; 3(10):e456-e466. PubMed ID: 27658980
[TBL] [Abstract][Full Text] [Related]
13. Acute Central Nervous System Complications in Pediatric Acute Lymphoblastic Leukemia.
Baytan B; Evim MS; Güler S; Güneş AM; Okan M
Pediatr Neurol; 2015 Oct; 53(4):312-8. PubMed ID: 26202590
[TBL] [Abstract][Full Text] [Related]
14. Physical exercise training interventions for children and young adults during and after treatment for childhood cancer.
Braam KI; van der Torre P; Takken T; Veening MA; van Dulmen-den Broeder E; Kaspers GJ
Cochrane Database Syst Rev; 2013 Apr; (4):CD008796. PubMed ID: 23633361
[TBL] [Abstract][Full Text] [Related]
15. Corticosteroid induced tumor lysis syndrome in acute lymphoblastic leukemia.
Rajagopal S; Lipton JH; Messner HA
Am J Hematol; 1992 Sep; 41(1):66-7. PubMed ID: 1503105
[No Abstract] [Full Text] [Related]
16. Risk factors for steroid-induced affective disorder in children with leukemia.
Muriel AC; Burgers DE; Treyball AN; Vrooman LM; Adolf E; Samsel C
Pediatr Blood Cancer; 2021 May; 68(5):e28847. PubMed ID: 33305874
[TBL] [Abstract][Full Text] [Related]
17. Degree of fatness after treatment for acute lymphoblastic leukemia in childhood.
Nysom K; Holm K; Michaelsen KF; Hertz H; Müller J; Mølgaard C
J Clin Endocrinol Metab; 1999 Dec; 84(12):4591-6. PubMed ID: 10599724
[TBL] [Abstract][Full Text] [Related]
18. The relationship between cognitive and neuroimaging outcomes in children treated for acute lymphoblastic leukemia with chemotherapy only: A systematic review.
Hearps S; Seal M; Anderson V; McCarthy M; Connellan M; Downie P; De Luca C
Pediatr Blood Cancer; 2017 Feb; 64(2):225-233. PubMed ID: 27696698
[TBL] [Abstract][Full Text] [Related]
19. Central nervous system chemotoxicity during treatment of pediatric acute lymphoblastic leukemia/lymphoma.
Vagace JM; de la Maya MD; Caceres-Marzal C; Gonzalez de Murillo S; Gervasini G
Crit Rev Oncol Hematol; 2012 Nov; 84(2):274-86. PubMed ID: 22578745
[TBL] [Abstract][Full Text] [Related]
20. Acute neurotoxicity in children with B-precursor acute lymphoid leukemia: an association with intermediate-dose intravenous methotrexate and intrathecal triple therapy--a Pediatric Oncology Group study.
Mahoney DH; Shuster JJ; Nitschke R; Lauer SJ; Steuber CP; Winick N; Camitta B
J Clin Oncol; 1998 May; 16(5):1712-22. PubMed ID: 9586883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
